GRAM GOLD FLORA CORPORATION
- 0.230
- +0.010+4.55%
GOLD FLORA CORPORATION News
Earnings Call Summary | GOLD FLORA CORPORATION(GRAM.US) Q1 2024 Earnings Conference
The following is a summary of the Gold Flora Corporation (GRAM) Q1 2024 Earnings Call Transcript:Financial Performance:Gold Flora Corporation reported a 13% sequential increase in its Q1 2024 revenue
10-Q: Quarterly report
Earnings Flash (GRAM) GOLD FLORA CORPORATION Posts Q1 Revenue $32.2M
07:05 AM EDT, 05/15/2024 (MT Newswires) -- Earnings Flash (GRAM) GOLD FLORA CORPORATION Posts Q1 Revenue $32.2M
Express News | Gold Flora Reports First Quarter 2024 Financial Results
4/20 Cannabis Retail Frenzy: Leading Brands Ready For Record Sales Surge - Who Will Lead?
This 4/20 cannabis retailers anticipate record-breaking sales fueled by last year's +130% spike and the fortunate alignment of this year's celebration falling on a Saturday. As dispensaries gear up fo
Express News | From Benzinga's Cannabis Capital Conference: Gold Flora CEO Laurie Holcomb Says "We Are In A Knife Fight In California"; California Medical Market Since 1998; Gold Flora Built Own Supply Chain; Seed to Sail; Cultivate Manufacture Distribute; See Us Expand
Woman-Owned Gold Flora's Strategic Cannabis Blueprint: 30% In-House Sales Boost, Profits, EBITDA Rise
In recent evaluations by Zuanic & Associates and Water Tower Research LLC, Gold Flora Corporation (OTC:GRAM), a key player in the competitive California cannabis market, reported its financial outcome
Gold Flora Corporation (PNK:GRAM) Q4 2023 Earnings Call Transcript
California's Underground Marijuana Market Flourishes: Which Companies Remain Resilient Amid Illicit Competition?
Sales Decline And Market Dynamics Recent market updates suggest a decline in California's cannabis sector despite a consistent number of licensed storefronts. Sales dropped 5% sequentially and year-ov
Earnings Call Summary | GOLD FLORA CORPORATION(GRAM.US) Q4 2023 Earnings Conference
The following is a summary of the Gold Flora Corporation (GRAM) Q4 2023 Earnings Call Transcript:Financial Performance:Gold Flora Corporation reported a Q4 2023 revenue of $28.4 million, decreased fro
Female-Led California Weed Co. Gold Flora's Net Loss Grows In Q4, Reports YoY Increase In Revenue & Gross Profit
Vertically-integrated California cannabis company Gold Flora Corporation (OTC:GRAM) announced its financial results on Friday for the three-month and twelve-month period ended Dec. 31, 2023."We have s
Gold Flora Reports Q4 Results
California's Weed Sales Decline: Market Ripe For Consolidation, Biggest Companies Likely To Benefit
The California cannabis sector is facing a sales decline, according to a recent market update from Pablo Zuanic, senior equity research analyst at Zuanic & Associates. The report contends that despite
Gold Flora Reschedules Fourth Quarter and Full Year 2023 Financial Results Filing to April 1, 2024
Gold Flora to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
Inside Benzinga's California Cannabis Spotlight: Key Takeaways On The Water Tower Podcast
In a recent episode of The Water Tower Hour podcast, Benzinga's Elliot Lane illuminated the diverse and dynamic California cannabis industry with insights from the company's inaugural regional event h
Gold Flora Mourns the Passing of Chairman Troy Datcher
Glass House Brands CEO Kyle Says 'I Think California Is Going to Be the Very, Very Big Winner in Cannabis When We Can Get All the Chains Taken off Our Wrists'
"Today, it's retailers getting absolutely crushed. And when they get crushed, the brands get crushed. So if you're an investor, I would say you have to be very cautious right now.""If you grow indoors
Golden Ticket To California Cannabis Retail? Gold Flora's Valuation & Potential, Overweight Initiation By Zuanic
Equity research firm Zuanic & Associates led by senior analyst Pablo Zuanic has initiated coverage of Gold Flora (OTC:GRAM) with an Overweight rating. This coverage comes at a time when the California
Express News | Zuanic & Associates Initiates Coverage On Gold Flora With Overweight Rating
Analysis
Price Target
No Data
